Society of Gynecologic Oncology Publications
- Equality, equity, and parity in the workplace are necessary to optimize patient care across all aspects of medicine. Gender-based inequities remain an obstacle to quality of care, including within the now majority women subspecialty of gynecologic oncology. The results of the 2020 SGO State of the Society Survey prompted this evidence-based review. Evidence related to relevant aspects of the clinical care model by which women with malignancies are cared for is summarized. Recommendations are made that include ways to create work environments where all members of a gynecologic oncology clinical care team, regardless of gender, can thrive.
- The human papilloma virus (HPV) vaccine was first approved by the Federal Drug Administration (FDA) in 2006 for prevention of cervical and lower genital tract cancer and genital warts. In June 2020, the HPV vaccine received accelerated approval from the FDA to add prevention of HPV-related oropharyngeal and other head and neck cancers as a vaccine indication . Results from population-based studies in the United States (US) and abroad demonstrate clinical vaccine efficacy with decreases in prevalence of genital warts, cervical dysplasia and cancer.
- Uterine serous carcinoma (USC) is an aggressive subtype of endometrial cancer. Multimodality treatment with surgery, radiotherapy, and chemotherapy is commonly used, given its propensity for extrauterine spread, distant recurrences, and poor prognosis. However, the use of molecularly-based therapy is expanding. Here, we review key molecular features of USC, discuss current management, and assess the landscape of novel therapies and combinations.
- The COVID-19 pandemic has challenged our ability to provide timely surgical care for our patients. In response, the U.S. Surgeon General, the American College of Srugeons, and other surgical professional societies recommended postponing elective surgical procedures and proceeding cautiously with cancer procedures that may require significant hospital resources and expose vulnerable patients to the virus. These challenges have particularly distressing for women with a gynecologic cancer diagnosis and their providers.
- The total cost of cancer care in the United States continues to rise and is estimated to range from 172 to 206 billion dollars per year by 2020 . This has important implications for our healthcare system's sustainability as well as for cancer patients who are at increased risk for experiencing significant financial strain due to out-of-pocket costs [1–3]. The National Academy of Medicine (formerly Institute of Medicine) endorses efforts to “improve the affordability of cancer care by leveraging existing efforts to reform payment and eliminate waste” .
- Trainee well-being is a core component of ACGME program requirements and the SGO has recognized the high incidence of burnout among gynecologic oncologists and its negative impact. To foster a culture of wellness throughout the SGO community we sought to engage current fellows along with fellowship directors in a structured didactic program designed to teach wellness. We evaluated the feasibility of and preliminary responses to a pilot curriculum designed to teach skills that promote wellness and prevent burnout.